DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

143.85 -0.65 (-0.45%)

REAL-TIME: Last trade at

Extended Hours: $143.87 $0.02 (0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

SLXP $143.85 -0.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $147.14
Previous Close $144.50
Daily Range $143.56 - $147.51
52-Week Range $70.64 - $172.98
Market Cap $9.2B
P/E Ratio 168.02
Dividend (Yield) $0.00 (0.0%)
Volume 1,286,418
Average Daily Volume 2,285,379
Current FY EPS $0.41

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary

Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?

Valeant Pharmaceuticals upped its bid offer for Botox maker Allergan by $15 a share yesterday. Actavis reportedly responded with an even richer offer. Will activist investor Bill Ackman get his way or will six months of work go down the drain?

Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings

Will Activis Win Competition For Allergan's Affection?

Sector Update: Health Care Stock Retreat; Shire Tumbles After Abbvie Reconsiders $55 Bln Inversion D

Sector Update: Health Care Stock Retreat; Shire Tumbles After Abbvie Reconsiders $55 Bln Inversion Deal

Sector Update: Health Care

These companies love seeing a stronger dollar

Allergan Raises Outlook amidst Valeant Takeover Attempts - Analyst Blog

Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share

Salix's Rectal Foam Uceris Receives Final FDA Approval - Analyst Blog

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog

See More SLXP News...

SLXP's Top Competitors

SLXP $143.85 (-0.45%)
Current stock: SLXP
JNJ $107.78 (0.69%)
Current stock: JNJ
NVS $92.69 (0.80%)
Current stock: NVS
RHHBY $36.81 (-1.00%)
Current stock: RHHBY